SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-24-090021
Filing Date
2024-08-02
Accepted
2024-08-02 16:30:18
Documents
17
Period of Report
2024-09-25

Document Format Files

Seq Description Document Type Size
1 PRE 14A drrx-20240802.htm   iXBRL PRE 14A 1271709
2 GRAPHIC img100790627_0.jpg GRAPHIC 6236
3 GRAPHIC img100790627_1.jpg GRAPHIC 127831
4 GRAPHIC img100790627_2.jpg GRAPHIC 123652
5 GRAPHIC img100790627_3.jpg GRAPHIC 707356
6 GRAPHIC img100790627_4.jpg GRAPHIC 314154
  Complete submission text file 0000950170-24-090021.txt   4887259

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT drrx-20240802.xsd EX-101.SCH 7924
19 EXTRACTED XBRL INSTANCE DOCUMENT drrx-20240802_htm.xml XML 193965
Mailing Address 10240 BUBB ROAD CUPERTINO CA 95014
Business Address 10240 BUBB ROAD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

IRS No.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-31615 | Film No.: 241171484
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)